SlideShare a Scribd company logo
1 of 24
 
Continuing Education
 Nausea and vomiting:
o Nausea and vomiting are two of the most common side effects
of chemotherapy.
o Vomiting is a reflex controlled in the emetic center of the brain
stem.
o Uncontrolled nausea and vomiting can lead to fluid and
electrolyte imbalance, impaired nutrition, nonadherence to
treatment, and a reduced quality of life.
 Nausea and vomiting can be prevented in 70% - 80% of
patients with the use if antiemetics (drugs that relieve the
signs and symptoms of nausea and vomiting).
 There are three patterns of emesis associated with
chemo administration:
1. Acute emesis occurs in the first 24 hours and is the most
severe.
2. Delayed emesis begins 18-24 hours after treatment and
may continue for several days.
3. Anticipatory emesis is a response that is triggered by
chemo-associated sights, smells, visual, thoughts and
anxiety.
 Antiemetic guidelines have been developed by the
American Society of Clinical Oncology (ASCO). The
Multinational Association of Supportive Care in Cancer
(MASCC), and the National Cancer Comprehensive
Network (NCCN).
o Acute chemo-induced N&V are prevented and treated with
serotonin receptor antagonists, dexamethasone, and
aprepitant.
o Delayed N&V are treated with dexamethasone and
aprepitant.
o Anticipatory N&V are treated with cognitive therapy and
benzodiazapines.
Classes of Antiemetics:
 Serotonin receptor antagonists are the most effective
agents to prevent acute N&V.
o They are administered immediately before chemotherapy
and continued for a few days.
o There are a number of these agents available:
• Anzemet (dolasetron)
• Kytril (granisteron)
• Zofran (ondansetron)
• Aloxil (palonestron)
o The major side effects of these drugs are headache,
diarrhea, fatigue, fever, and drowsiness
 Neurokinin-1-Receptor Antagonists:
o These block the NK-1 receptor, which is found in the
vomiting and vestibular center of the brain.
o The only drugs in this class currently available.
1. Emend for injection (fosaprepitant dimeglumine)
2. Emend oral (aprepitant)
o When combined with a serotonin receptor antagonist and
dexamethasone therapy, they have added efficacy in both
acute and delayed N&V.
 Corticosteroids
o Dexamethasone is the most commonly used antiemetic
corticosteroid.
o Corticosteroids are important in the prevention of delayed
N&V.
o Common S/E with short term use include insomnia, gastric
irritation, and transient hyperglycemia.
 Dopamine receptor antagonists include..
o Reglan (metoclopramide)
o Compazine (prochlorperazine)
o Phenergan (promethazine)
o Haldol (haloperidol)
o Efficacy is low when these agents are used alone, they are
sometimes used in conjunction with other antiemetics for
breakthrough emesis.
 Benzodiazepines
o Benzodiazepines can reduce anxiety some patients experience
before and during chemotherapy.
o They are not antiemetics but are used in conjunction with
antiemetics.
 Nonpharmacological Measures to control Nausea & Vomiting:
o There are several nursing measures that may help reduce N&V.
o Patients should avoid eating or drinking 1-2 hours after chemo
treatments.
o Many patients find that foods at room temperature taste better and do
not have as strong of an odor as hot foods.
o Dry toast or crackers in the morning may help the patient’s nausea.
o Clear liquids and herbal tea provide fluids to prevent dehydration.
o Sport drinks also provide electrolytes.
o Liquids should be sipped slowly.
o Some tart foods such as sour hard candy, dill pickles or lemons may be
helpful for some patients.
o Foods such as fried fatty foods or foods with a strong odor should be
avoided.
o Soft, relaxing music; low lights and quiet atmosphere may be helpful.
Some patients do well with diversions such as card games, movies or
crafts.
o Some patients respond well to acupressure, acupuncture, behavior
modification, yoga, massage therapy, hypnosis, and guided imagery.
 Myelosuppression
o Myelosuppression is the most common dose-limiting factor
in chemotherapy administration.
o Myelosuppression consists of neutropenia,
thrombocytopenia, and anemia.
 Neutropenia
o Patients with neutropenia have an unusually low number
of neutrophils. Neutrophils attack bacteria and other
organisms when they invade your body. Neutropenia
predisposes the patient to infection.
 Thrombocytopenia
o Normal platelet count ranges between 150,000 and 400,000.
Thrombocytopenia occurs when a patient has a low platelet count. The
risk of bleeding increases when the count is below 100,000.
 Anemia
o A patient is considered anemic if the Hgb level is < 8 g/dL. Anemic
patients may be symptomatic or present with headache, dizziness,
lightheadedness, SOB, fatigue, pallor, hypothermia, and pale nail beds
and conjunctiva.
 Fatigue
o Cancer related fatigue is the most common side effect of cancer and its
treatment.
o Exercise may reduce the intensity of fatigue and the distress associated
with its occurrence.
o Treatment of anemia may also be helpful.
 Anorexia and Taste Alterations:
o Anorexia and taste alterations are common among patients receiving
chemotherapy.
o Dysgeusia, a condition in which the gustatory sense is impaired. Foods taste
entirely different and in some circumstances even unpleasant.
o Some patients experience a metallic or bitter taste, or no taste at all.
o Advise the patient that gum or hard candy can help between meals.
o Instruct the patient to brush teeth frequently to relieve unpleasant tastes.
o Rinsing the mouth with non irritating mouthwash is often refreshing.
o Cold foods or foods served at room temp are usually tolerated better than hot
foods, cold fruits and cheeses are often a better alternative than a hot meal.
Small more frequent meals may be tolerated better than three large meals.
o Hard, dry food can cause discomfort and be difficult to swallow as compared
to soft meals.
o Commercial mouthwashes, smoking, and alcohol are irritating to the mucous
membranes and should be avoided.
 Nursing suggestions to help patients cope with taste
alterations:
o Provide oral hygiene before meals.
o Avoid strong cooking odors, such as cabbage and broccoli.
o Arrange food attractively.
o Eat in pleasant, relaxed environment.
o Use pleasant odors, such as cloves.
o Avoid noxious odors, such as fish.
o Enhance food flavors with herbs, spices, or marinade.
o Serve cold foods rather than hot foods.
o Eat frequent, small meals.
o Administer antiemetics before meals.
o Drink high energy shakes.
o Serve food on glass dishes and use plastic silverware.
 Constipation
o Constipation is the difficult, and sometimes painful, passage of
hard, dry stool. It can vary from mild discomfort to the
development of a paralytic ileus.
o There are many causes including Chemotherapy, anxiety,
depression, opioids, muscle relaxants, hypercalcemia,
immobility, dehydration, dietary deficiencies, and tumor
involvement.
o Patients at risk for constipation should be instructed to increase
their dietary intake of fresh fruits, vegetables, and fiber. The
patient should has at least 2 to 3 liters of fluid daily unless
otherwise contraindicated.
o Cheese, eggs, chocolate, candy, and foods known to be
constipating should be avoided.
o Physical activity and exercise stimulate peristalsis, patients
should be encouraged to remain as active as possible.
o Patients should be instructed to respond to the urge to defecate
and not wait.
 Diarrhea
o Diarrhea is the abnormal passage of five or more loose or watery
stools in a 24 hour period, often it is accompanied by abdominal
cramping.
o Patients with 6 or more diarrhea stools a day are at risk for
dehydration and electrolyte imbalance.
o Instruct the patient to increase their intake of constipating foods
such as cheese and eggs.
o Foods high in pectin, bulk, and fiber help slow peristalsis. Fluid
replacement prevents dehydration.
o Avoid spicy foods, which irritate the GI tract.
o Advise patients that fatty or greasy foods stimulate the colon.
o Raw fruits and vegetables, nuts, caffeine, seeds, popcorn, and
alcohol should be avoided.
 Diarrhea (cont’d)
o Intake and output should be accurately recorded.
o Potassium is one of the major electrolytes lost;
therefore fluids and foods high in potassium should
be used.
o Pharmacological intervention should be started as
soon as possible to avoid complications.
o In cases of severe diarrhea, IV fluid replacement and
anti motility agents (such as loperamide ,
diphenoxylate, or octreotide) may be indicated.
 Alopecia
o Although hair loss is temporary, alopecia may adversely affect
self image.
o Rapidly dividing cells, including the hair follicles, are affected by
chemotherapy.
o Hair loss may be thinning, partial, or complete, and may involve
the scalp, eyebrows, and eyelashes.
o Hair loss may begin in 7-10 days after treatment, but sometimes
begins even before treatment is completed.
o Regrowth usually occurs 3-6 months after the last treatment.
o Care of the scalp should be the same as that for any area of
exposed skin.
 Stomatitis and Mucositis
o The mucous membranes of the GI tract, especially those of the mouth,
can become red, irritated, and inflamed.
o Stomatitis can range from a mild irritation to full blown sores, with
difficulty swallowing.
o Chemo related stomatitis usually begins 5-7 days after treatment and
lasts about 10 days.
o Educate patient on good oral hygiene.
o A soft toothbrush should be used, particular when mouth is tender.
o Advise patients to remove their dentures at night and as much as
possible during the day.
o Instruct patients to eat soft foods with a smooth consistency. Cold foods
may be soothing to irritated membranes.
o Applying lip balm deeps the lips moist and promotes comfort and
healing.
o Ice chips have been used effectively to prevent or reduce mucositis in
 Cardiotoxicity
o Cardiotoxic chemo agents include the anthracyclines,
doxorubicin and daunorubicin, mitoxantrone, paclitaxel, and, in
high doses, cyclophosphamide.
o The anthracyclines can damage the myocytes, weakening the
cardiac muscle. This results in decreased cardiac output, with
progression to congestive heart failure.
o A patient is usually asymptomatic until s/s of CHF appear.
Patients c/o SOB, especially on exertion, and a nonproductive
cough.
o The physical exam shows neck vein distention, tachycardia,
gallop rhythm, and edema.
o A drop in the baseline ejection fraction signals a decrease in left
ventricular function. At this point one must weigh the risk of
cardiac damage against a meaningful tumor response.
o Frequent monitoring of the EKG helps to identify early sign of
impending toxicity.
 Neurotoxicity
o Neurotoxicity may affect the central nervous system or the
peripheral nervous system.
o CNS toxicity includes encephalopathy, seizures, cerebellar
dysfunction, mental status changes, opthalmic toxicity, and
ototoxicity.
o Peripheral toxicity causes axonal degeneration or
demyelination involving sensory and motor dysfunction.
o Paclitaxel, cisplatin, carboplatin, and the vinca alkaloids
are the agents most likely to cause neurotoxicity.
o Peripheral neuropathy usually does not occur until after
five or more treatments.
o As the toxicity increases, the patient complains of muscle
pain, weakness, and disturbances in depth perception,
particularly with ambulation.
 Neurotoxicity- cont’d:
o Patients need to be cautioned about loose rugs, steps, and
articles lying on the floor that may cause the patient to trip.
o Because there is a decrease in sensation, the patient needs to
use caution when using hot water, heating pads, electric
blankets, hot stoves, and radiators.
o Exposure to cold is also a concern. Patients should dress warm
and use protection against the cold on their hands and feet.
o Paralytic ileus and constipation are also concerns of this patient
population.
o Symptoms can manifest within 2 days, and especially in patients
receiving vinca alkaloids.
o The patient should be observed for abdominal distention and
active bowel sounds. Fresh fruits and vegetables, fiber, and
fluids should be added to the diet. Constipation may be
compounded in the patient who is also receiving narcotics. Stool
softeners may be helpful
 Renal Toxicity:
o Chemotherapeutic agents that may cause renal toxicity are
cisplatin, carmustine, streptozocin, methotrexate, mytomycin-cm
and, to a lesser degree, carboplatin. Concurrent administration
of amphotericin, aminoglycoside antibiotics, and vitamin c
potentiates nephrotoxcity.
o BUN and creatinine levels need to be obtained prior to
administration of the nephrotoxic agents.
o Vigorous hydration is often administered before nephrotoxic
agents. Mannitol and Lasix may also be given to promote
diuresis.
 Pulmonary Toxicity
o A few chemotherapy agents can damage the endothelial cells of
the lung. Bleomycin at dosages exceeding 400 units and
carmustin in total doses of 1500mg/m2 predispose patients to
pneumonitis and interstitial fibrosis. Toxicity can be increase with
concurrent use of cyclophosphamide. Other agents include
mitomycin and methotrexate.
o The patient usually presents with dyspnea, a nonproductive
cough, fatigue, and fever. Lung sounds produce inspiratory
bibasilar rales.
o Elderly patients and patients with a smoking history, or a
pulmonary condition appear to be at greater risk for pulmonary
toxicity.
 Sexual and Reproductive Malfunction
o Chemo adversely affects gonadal function. Preservation of
fertility is an active area of research.
o In males, chemo reduces the sperm count and temporary or
permanent infertility may result.
o Chemo suppresses ovarian function in women. Within 6 months
of receiving chemo, women may experience amenorrhea or
changes in their menstrual cycle.
o Many women experience s/s of a medical menopause, including
hot flashes, irritability, insomnia, and vaginal dryness.
o Gametes or embryos may be frozen before chemotherapy.
o There is also interest in protecting the ovaries by using a
gonadotropin-releasing hormone analogs during chemotherapy.

More Related Content

What's hot

Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancerSudip Das
 
Radiation therapy
Radiation therapyRadiation therapy
Radiation therapyRad Tech
 
Cancer chemo therapy
Cancer chemo therapyCancer chemo therapy
Cancer chemo therapyArifa T N
 
Oncological Emergencies- Oncology Nursing
Oncological Emergencies- Oncology NursingOncological Emergencies- Oncology Nursing
Oncological Emergencies- Oncology NursingSwatilekha Das
 
chemotherapy administration
chemotherapy administrationchemotherapy administration
chemotherapy administrationNisha Yadav
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surgNehaNupur8
 
Introduction to radiation oncology nursing
Introduction to radiation oncology nursingIntroduction to radiation oncology nursing
Introduction to radiation oncology nursingMathew Varghese V
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lmsNilesh Kucha
 
Modalities of treatment for cancer
Modalities of treatment for cancerModalities of treatment for cancer
Modalities of treatment for cancerANILKUMAR BR
 
Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancerDr Sachin Prakash
 
MANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMAMANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMASuraj Dhara
 
Principles of chemotherapy ppt
Principles of chemotherapy pptPrinciples of chemotherapy ppt
Principles of chemotherapy pptmadurai
 
Oncological Emergencies & Treatment Modalities.pptx
Oncological Emergencies & Treatment Modalities.pptxOncological Emergencies & Treatment Modalities.pptx
Oncological Emergencies & Treatment Modalities.pptxAsokan R
 
Nursing care of radiation
Nursing care of radiationNursing care of radiation
Nursing care of radiationshayiamk
 

What's hot (20)

Oncological emergencies
Oncological emergenciesOncological emergencies
Oncological emergencies
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
Colorectal Cancer
Colorectal CancerColorectal Cancer
Colorectal Cancer
 
Radiation therapy
Radiation therapyRadiation therapy
Radiation therapy
 
Cancer chemo therapy
Cancer chemo therapyCancer chemo therapy
Cancer chemo therapy
 
Colon cancer
Colon cancer Colon cancer
Colon cancer
 
Cancer of bladder
Cancer of bladderCancer of bladder
Cancer of bladder
 
Oncological Emergencies- Oncology Nursing
Oncological Emergencies- Oncology NursingOncological Emergencies- Oncology Nursing
Oncological Emergencies- Oncology Nursing
 
chemotherapy administration
chemotherapy administrationchemotherapy administration
chemotherapy administration
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
 
Management of cancer
Management of cancerManagement of cancer
Management of cancer
 
Introduction to radiation oncology nursing
Introduction to radiation oncology nursingIntroduction to radiation oncology nursing
Introduction to radiation oncology nursing
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
 
Modalities of treatment for cancer
Modalities of treatment for cancerModalities of treatment for cancer
Modalities of treatment for cancer
 
Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancer
 
Brain cancer (tumors)
Brain cancer (tumors)Brain cancer (tumors)
Brain cancer (tumors)
 
MANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMAMANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMA
 
Principles of chemotherapy ppt
Principles of chemotherapy pptPrinciples of chemotherapy ppt
Principles of chemotherapy ppt
 
Oncological Emergencies & Treatment Modalities.pptx
Oncological Emergencies & Treatment Modalities.pptxOncological Emergencies & Treatment Modalities.pptx
Oncological Emergencies & Treatment Modalities.pptx
 
Nursing care of radiation
Nursing care of radiationNursing care of radiation
Nursing care of radiation
 

Similar to 2. Side effects and toxicities of chemotherapy

Aniemetics, Emetics, Purgatives Drugs
Aniemetics, Emetics, Purgatives DrugsAniemetics, Emetics, Purgatives Drugs
Aniemetics, Emetics, Purgatives DrugsRoshani Naik
 
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docxSOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docxrosemariebrayshaw
 
ADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsGyanshankar Mishra
 
Dental management for Medically Compromised Patients 2
Dental management for Medically Compromised Patients 2Dental management for Medically Compromised Patients 2
Dental management for Medically Compromised Patients 2Haydar Mahdey
 
"Management of the Patient Irradiated for Head and Neck Cancer"
"Management of the Patient Irradiated for Head and Neck Cancer""Management of the Patient Irradiated for Head and Neck Cancer"
"Management of the Patient Irradiated for Head and Neck Cancer"Jansen Calibo
 
chemo for study day finshed_.pptx
chemo for study day finshed_.pptxchemo for study day finshed_.pptx
chemo for study day finshed_.pptxadityasingla007
 
Care of an unconcious patient
Care of an unconcious patientCare of an unconcious patient
Care of an unconcious patientJyoti Gaver
 
therapies in psychiatry 1111111111111111
therapies in psychiatry 1111111111111111therapies in psychiatry 1111111111111111
therapies in psychiatry 1111111111111111MaryemSafdar2
 
Hepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsHepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsDreams Higher
 
Chemotherpy of nausea and emesis
Chemotherpy of nausea and emesisChemotherpy of nausea and emesis
Chemotherpy of nausea and emesisWazeed Basha
 
Therapeutic modalities in psychiatry
Therapeutic modalities in psychiatryTherapeutic modalities in psychiatry
Therapeutic modalities in psychiatryEnoch R G
 
Drugs Affecting Gastrointestinal Tract.pptx
Drugs Affecting Gastrointestinal Tract.pptxDrugs Affecting Gastrointestinal Tract.pptx
Drugs Affecting Gastrointestinal Tract.pptxHiraKhan218459
 
Case selection part 2 ( systemic factors )
Case selection part 2 ( systemic factors )Case selection part 2 ( systemic factors )
Case selection part 2 ( systemic factors )Mohammad Omar
 
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...Kanwarpal Dhillon
 

Similar to 2. Side effects and toxicities of chemotherapy (20)

Aniemetics, Emetics, Purgatives Drugs
Aniemetics, Emetics, Purgatives DrugsAniemetics, Emetics, Purgatives Drugs
Aniemetics, Emetics, Purgatives Drugs
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Poisoning Ppt.pdf
Poisoning Ppt.pdfPoisoning Ppt.pdf
Poisoning Ppt.pdf
 
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docxSOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
 
Constipation.pptx
Constipation.pptxConstipation.pptx
Constipation.pptx
 
ADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis Drugs
 
Dental management for Medically Compromised Patients 2
Dental management for Medically Compromised Patients 2Dental management for Medically Compromised Patients 2
Dental management for Medically Compromised Patients 2
 
Case study.
Case study.Case study.
Case study.
 
"Management of the Patient Irradiated for Head and Neck Cancer"
"Management of the Patient Irradiated for Head and Neck Cancer""Management of the Patient Irradiated for Head and Neck Cancer"
"Management of the Patient Irradiated for Head and Neck Cancer"
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
chemo for study day finshed_.pptx
chemo for study day finshed_.pptxchemo for study day finshed_.pptx
chemo for study day finshed_.pptx
 
Care of an unconcious patient
Care of an unconcious patientCare of an unconcious patient
Care of an unconcious patient
 
therapies in psychiatry 1111111111111111
therapies in psychiatry 1111111111111111therapies in psychiatry 1111111111111111
therapies in psychiatry 1111111111111111
 
Hepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsHepatic encephalopathy by dreams
Hepatic encephalopathy by dreams
 
Chemotherpy of nausea and emesis
Chemotherpy of nausea and emesisChemotherpy of nausea and emesis
Chemotherpy of nausea and emesis
 
Therapeutic modalities in psychiatry
Therapeutic modalities in psychiatryTherapeutic modalities in psychiatry
Therapeutic modalities in psychiatry
 
Drugs Affecting Gastrointestinal Tract.pptx
Drugs Affecting Gastrointestinal Tract.pptxDrugs Affecting Gastrointestinal Tract.pptx
Drugs Affecting Gastrointestinal Tract.pptx
 
Case selection part 2 ( systemic factors )
Case selection part 2 ( systemic factors )Case selection part 2 ( systemic factors )
Case selection part 2 ( systemic factors )
 
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...
Intoxication emergency (amitraz, chocolate, ivermectin, rodenticide, acetamin...
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 

More from ChartwellPA

CHF and Inotropes
CHF and InotropesCHF and Inotropes
CHF and InotropesChartwellPA
 
1. Chemo in the home
1. Chemo in the home1. Chemo in the home
1. Chemo in the homeChartwellPA
 
3. Transitioning to home setting
3. Transitioning to home setting3. Transitioning to home setting
3. Transitioning to home settingChartwellPA
 
4. injection caps
4. injection caps4. injection caps
4. injection capsChartwellPA
 
3. central line associated blood stream infection
3. central line associated blood stream infection3. central line associated blood stream infection
3. central line associated blood stream infectionChartwellPA
 
2. central venous access devices (cvads)
2. central venous access devices (cvads)2. central venous access devices (cvads)
2. central venous access devices (cvads)ChartwellPA
 
1. peripheral and midline iv lines
1. peripheral and midline iv lines1. peripheral and midline iv lines
1. peripheral and midline iv linesChartwellPA
 
5. Insurance considerations
5. Insurance considerations5. Insurance considerations
5. Insurance considerationsChartwellPA
 
4. Transitioning to home setting
4. Transitioning to home setting4. Transitioning to home setting
4. Transitioning to home settingChartwellPA
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutritionChartwellPA
 
2. Assessing the need for tpn
2. Assessing the need for tpn2. Assessing the need for tpn
2. Assessing the need for tpnChartwellPA
 
1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs itChartwellPA
 

More from ChartwellPA (13)

CHF and Inotropes
CHF and InotropesCHF and Inotropes
CHF and Inotropes
 
1. Chemo in the home
1. Chemo in the home1. Chemo in the home
1. Chemo in the home
 
3. Transitioning to home setting
3. Transitioning to home setting3. Transitioning to home setting
3. Transitioning to home setting
 
Enteral
EnteralEnteral
Enteral
 
4. injection caps
4. injection caps4. injection caps
4. injection caps
 
3. central line associated blood stream infection
3. central line associated blood stream infection3. central line associated blood stream infection
3. central line associated blood stream infection
 
2. central venous access devices (cvads)
2. central venous access devices (cvads)2. central venous access devices (cvads)
2. central venous access devices (cvads)
 
1. peripheral and midline iv lines
1. peripheral and midline iv lines1. peripheral and midline iv lines
1. peripheral and midline iv lines
 
5. Insurance considerations
5. Insurance considerations5. Insurance considerations
5. Insurance considerations
 
4. Transitioning to home setting
4. Transitioning to home setting4. Transitioning to home setting
4. Transitioning to home setting
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutrition
 
2. Assessing the need for tpn
2. Assessing the need for tpn2. Assessing the need for tpn
2. Assessing the need for tpn
 
1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs it
 

Recently uploaded

Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 

Recently uploaded (20)

Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 

2. Side effects and toxicities of chemotherapy

  • 2.  Nausea and vomiting: o Nausea and vomiting are two of the most common side effects of chemotherapy. o Vomiting is a reflex controlled in the emetic center of the brain stem. o Uncontrolled nausea and vomiting can lead to fluid and electrolyte imbalance, impaired nutrition, nonadherence to treatment, and a reduced quality of life.  Nausea and vomiting can be prevented in 70% - 80% of patients with the use if antiemetics (drugs that relieve the signs and symptoms of nausea and vomiting).
  • 3.  There are three patterns of emesis associated with chemo administration: 1. Acute emesis occurs in the first 24 hours and is the most severe. 2. Delayed emesis begins 18-24 hours after treatment and may continue for several days. 3. Anticipatory emesis is a response that is triggered by chemo-associated sights, smells, visual, thoughts and anxiety.
  • 4.  Antiemetic guidelines have been developed by the American Society of Clinical Oncology (ASCO). The Multinational Association of Supportive Care in Cancer (MASCC), and the National Cancer Comprehensive Network (NCCN). o Acute chemo-induced N&V are prevented and treated with serotonin receptor antagonists, dexamethasone, and aprepitant. o Delayed N&V are treated with dexamethasone and aprepitant. o Anticipatory N&V are treated with cognitive therapy and benzodiazapines.
  • 5. Classes of Antiemetics:  Serotonin receptor antagonists are the most effective agents to prevent acute N&V. o They are administered immediately before chemotherapy and continued for a few days. o There are a number of these agents available: • Anzemet (dolasetron) • Kytril (granisteron) • Zofran (ondansetron) • Aloxil (palonestron) o The major side effects of these drugs are headache, diarrhea, fatigue, fever, and drowsiness
  • 6.  Neurokinin-1-Receptor Antagonists: o These block the NK-1 receptor, which is found in the vomiting and vestibular center of the brain. o The only drugs in this class currently available. 1. Emend for injection (fosaprepitant dimeglumine) 2. Emend oral (aprepitant) o When combined with a serotonin receptor antagonist and dexamethasone therapy, they have added efficacy in both acute and delayed N&V.
  • 7.  Corticosteroids o Dexamethasone is the most commonly used antiemetic corticosteroid. o Corticosteroids are important in the prevention of delayed N&V. o Common S/E with short term use include insomnia, gastric irritation, and transient hyperglycemia.
  • 8.  Dopamine receptor antagonists include.. o Reglan (metoclopramide) o Compazine (prochlorperazine) o Phenergan (promethazine) o Haldol (haloperidol) o Efficacy is low when these agents are used alone, they are sometimes used in conjunction with other antiemetics for breakthrough emesis.  Benzodiazepines o Benzodiazepines can reduce anxiety some patients experience before and during chemotherapy. o They are not antiemetics but are used in conjunction with antiemetics.
  • 9.  Nonpharmacological Measures to control Nausea & Vomiting: o There are several nursing measures that may help reduce N&V. o Patients should avoid eating or drinking 1-2 hours after chemo treatments. o Many patients find that foods at room temperature taste better and do not have as strong of an odor as hot foods. o Dry toast or crackers in the morning may help the patient’s nausea. o Clear liquids and herbal tea provide fluids to prevent dehydration. o Sport drinks also provide electrolytes. o Liquids should be sipped slowly. o Some tart foods such as sour hard candy, dill pickles or lemons may be helpful for some patients. o Foods such as fried fatty foods or foods with a strong odor should be avoided. o Soft, relaxing music; low lights and quiet atmosphere may be helpful. Some patients do well with diversions such as card games, movies or crafts. o Some patients respond well to acupressure, acupuncture, behavior modification, yoga, massage therapy, hypnosis, and guided imagery.
  • 10.  Myelosuppression o Myelosuppression is the most common dose-limiting factor in chemotherapy administration. o Myelosuppression consists of neutropenia, thrombocytopenia, and anemia.  Neutropenia o Patients with neutropenia have an unusually low number of neutrophils. Neutrophils attack bacteria and other organisms when they invade your body. Neutropenia predisposes the patient to infection.
  • 11.  Thrombocytopenia o Normal platelet count ranges between 150,000 and 400,000. Thrombocytopenia occurs when a patient has a low platelet count. The risk of bleeding increases when the count is below 100,000.  Anemia o A patient is considered anemic if the Hgb level is < 8 g/dL. Anemic patients may be symptomatic or present with headache, dizziness, lightheadedness, SOB, fatigue, pallor, hypothermia, and pale nail beds and conjunctiva.  Fatigue o Cancer related fatigue is the most common side effect of cancer and its treatment. o Exercise may reduce the intensity of fatigue and the distress associated with its occurrence. o Treatment of anemia may also be helpful.
  • 12.  Anorexia and Taste Alterations: o Anorexia and taste alterations are common among patients receiving chemotherapy. o Dysgeusia, a condition in which the gustatory sense is impaired. Foods taste entirely different and in some circumstances even unpleasant. o Some patients experience a metallic or bitter taste, or no taste at all. o Advise the patient that gum or hard candy can help between meals. o Instruct the patient to brush teeth frequently to relieve unpleasant tastes. o Rinsing the mouth with non irritating mouthwash is often refreshing. o Cold foods or foods served at room temp are usually tolerated better than hot foods, cold fruits and cheeses are often a better alternative than a hot meal. Small more frequent meals may be tolerated better than three large meals. o Hard, dry food can cause discomfort and be difficult to swallow as compared to soft meals. o Commercial mouthwashes, smoking, and alcohol are irritating to the mucous membranes and should be avoided.
  • 13.  Nursing suggestions to help patients cope with taste alterations: o Provide oral hygiene before meals. o Avoid strong cooking odors, such as cabbage and broccoli. o Arrange food attractively. o Eat in pleasant, relaxed environment. o Use pleasant odors, such as cloves. o Avoid noxious odors, such as fish. o Enhance food flavors with herbs, spices, or marinade. o Serve cold foods rather than hot foods. o Eat frequent, small meals. o Administer antiemetics before meals. o Drink high energy shakes. o Serve food on glass dishes and use plastic silverware.
  • 14.  Constipation o Constipation is the difficult, and sometimes painful, passage of hard, dry stool. It can vary from mild discomfort to the development of a paralytic ileus. o There are many causes including Chemotherapy, anxiety, depression, opioids, muscle relaxants, hypercalcemia, immobility, dehydration, dietary deficiencies, and tumor involvement. o Patients at risk for constipation should be instructed to increase their dietary intake of fresh fruits, vegetables, and fiber. The patient should has at least 2 to 3 liters of fluid daily unless otherwise contraindicated. o Cheese, eggs, chocolate, candy, and foods known to be constipating should be avoided. o Physical activity and exercise stimulate peristalsis, patients should be encouraged to remain as active as possible. o Patients should be instructed to respond to the urge to defecate and not wait.
  • 15.  Diarrhea o Diarrhea is the abnormal passage of five or more loose or watery stools in a 24 hour period, often it is accompanied by abdominal cramping. o Patients with 6 or more diarrhea stools a day are at risk for dehydration and electrolyte imbalance. o Instruct the patient to increase their intake of constipating foods such as cheese and eggs. o Foods high in pectin, bulk, and fiber help slow peristalsis. Fluid replacement prevents dehydration. o Avoid spicy foods, which irritate the GI tract. o Advise patients that fatty or greasy foods stimulate the colon. o Raw fruits and vegetables, nuts, caffeine, seeds, popcorn, and alcohol should be avoided.
  • 16.  Diarrhea (cont’d) o Intake and output should be accurately recorded. o Potassium is one of the major electrolytes lost; therefore fluids and foods high in potassium should be used. o Pharmacological intervention should be started as soon as possible to avoid complications. o In cases of severe diarrhea, IV fluid replacement and anti motility agents (such as loperamide , diphenoxylate, or octreotide) may be indicated.
  • 17.  Alopecia o Although hair loss is temporary, alopecia may adversely affect self image. o Rapidly dividing cells, including the hair follicles, are affected by chemotherapy. o Hair loss may be thinning, partial, or complete, and may involve the scalp, eyebrows, and eyelashes. o Hair loss may begin in 7-10 days after treatment, but sometimes begins even before treatment is completed. o Regrowth usually occurs 3-6 months after the last treatment. o Care of the scalp should be the same as that for any area of exposed skin.
  • 18.  Stomatitis and Mucositis o The mucous membranes of the GI tract, especially those of the mouth, can become red, irritated, and inflamed. o Stomatitis can range from a mild irritation to full blown sores, with difficulty swallowing. o Chemo related stomatitis usually begins 5-7 days after treatment and lasts about 10 days. o Educate patient on good oral hygiene. o A soft toothbrush should be used, particular when mouth is tender. o Advise patients to remove their dentures at night and as much as possible during the day. o Instruct patients to eat soft foods with a smooth consistency. Cold foods may be soothing to irritated membranes. o Applying lip balm deeps the lips moist and promotes comfort and healing. o Ice chips have been used effectively to prevent or reduce mucositis in
  • 19.  Cardiotoxicity o Cardiotoxic chemo agents include the anthracyclines, doxorubicin and daunorubicin, mitoxantrone, paclitaxel, and, in high doses, cyclophosphamide. o The anthracyclines can damage the myocytes, weakening the cardiac muscle. This results in decreased cardiac output, with progression to congestive heart failure. o A patient is usually asymptomatic until s/s of CHF appear. Patients c/o SOB, especially on exertion, and a nonproductive cough. o The physical exam shows neck vein distention, tachycardia, gallop rhythm, and edema. o A drop in the baseline ejection fraction signals a decrease in left ventricular function. At this point one must weigh the risk of cardiac damage against a meaningful tumor response. o Frequent monitoring of the EKG helps to identify early sign of impending toxicity.
  • 20.  Neurotoxicity o Neurotoxicity may affect the central nervous system or the peripheral nervous system. o CNS toxicity includes encephalopathy, seizures, cerebellar dysfunction, mental status changes, opthalmic toxicity, and ototoxicity. o Peripheral toxicity causes axonal degeneration or demyelination involving sensory and motor dysfunction. o Paclitaxel, cisplatin, carboplatin, and the vinca alkaloids are the agents most likely to cause neurotoxicity. o Peripheral neuropathy usually does not occur until after five or more treatments. o As the toxicity increases, the patient complains of muscle pain, weakness, and disturbances in depth perception, particularly with ambulation.
  • 21.  Neurotoxicity- cont’d: o Patients need to be cautioned about loose rugs, steps, and articles lying on the floor that may cause the patient to trip. o Because there is a decrease in sensation, the patient needs to use caution when using hot water, heating pads, electric blankets, hot stoves, and radiators. o Exposure to cold is also a concern. Patients should dress warm and use protection against the cold on their hands and feet. o Paralytic ileus and constipation are also concerns of this patient population. o Symptoms can manifest within 2 days, and especially in patients receiving vinca alkaloids. o The patient should be observed for abdominal distention and active bowel sounds. Fresh fruits and vegetables, fiber, and fluids should be added to the diet. Constipation may be compounded in the patient who is also receiving narcotics. Stool softeners may be helpful
  • 22.  Renal Toxicity: o Chemotherapeutic agents that may cause renal toxicity are cisplatin, carmustine, streptozocin, methotrexate, mytomycin-cm and, to a lesser degree, carboplatin. Concurrent administration of amphotericin, aminoglycoside antibiotics, and vitamin c potentiates nephrotoxcity. o BUN and creatinine levels need to be obtained prior to administration of the nephrotoxic agents. o Vigorous hydration is often administered before nephrotoxic agents. Mannitol and Lasix may also be given to promote diuresis.
  • 23.  Pulmonary Toxicity o A few chemotherapy agents can damage the endothelial cells of the lung. Bleomycin at dosages exceeding 400 units and carmustin in total doses of 1500mg/m2 predispose patients to pneumonitis and interstitial fibrosis. Toxicity can be increase with concurrent use of cyclophosphamide. Other agents include mitomycin and methotrexate. o The patient usually presents with dyspnea, a nonproductive cough, fatigue, and fever. Lung sounds produce inspiratory bibasilar rales. o Elderly patients and patients with a smoking history, or a pulmonary condition appear to be at greater risk for pulmonary toxicity.
  • 24.  Sexual and Reproductive Malfunction o Chemo adversely affects gonadal function. Preservation of fertility is an active area of research. o In males, chemo reduces the sperm count and temporary or permanent infertility may result. o Chemo suppresses ovarian function in women. Within 6 months of receiving chemo, women may experience amenorrhea or changes in their menstrual cycle. o Many women experience s/s of a medical menopause, including hot flashes, irritability, insomnia, and vaginal dryness. o Gametes or embryos may be frozen before chemotherapy. o There is also interest in protecting the ovaries by using a gonadotropin-releasing hormone analogs during chemotherapy.